Lipid management guidelines should be revised to reflect evidence of clinical benefits of lowering LDL-cholesterol levels below the current target of 1.8mmol/l, lipid researchers say. A meta-analysis of trials of statin and non-statin therapies has shown that reductions in major vascular events are apparent when LDL-C levels are lowered to 1.6 mmol/L and the benefits ...
Ischaemic heart disease
New guidelines needed to reflect benefits of lower LDL-cholesterol levels
2 Aug 2018